378 related articles for article (PubMed ID: 36362142)
1. Interplay between the DNA Damage Response and Immunotherapy Response in Cancer.
Lee ECY; Kok JST; Teh BT; Lim KS
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362142
[TBL] [Abstract][Full Text] [Related]
2. Genomic instability, inflammatory signaling and response to cancer immunotherapy.
Chen M; Linstra R; van Vugt MATM
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188661. PubMed ID: 34800547
[TBL] [Abstract][Full Text] [Related]
3. DNA repair defects in cancer and therapeutic opportunities.
Hopkins JL; Lan L; Zou L
Genes Dev; 2022 Mar; 36(5-6):278-293. PubMed ID: 35318271
[TBL] [Abstract][Full Text] [Related]
4. DNA Damage and Repair Biomarkers of Immunotherapy Response.
Mouw KW; Goldberg MS; Konstantinopoulos PA; D'Andrea AD
Cancer Discov; 2017 Jul; 7(7):675-693. PubMed ID: 28630051
[TBL] [Abstract][Full Text] [Related]
5. DNA repair defects and implications for immunotherapy.
Bever KM; Le DT
J Clin Invest; 2018 Oct; 128(10):4236-4242. PubMed ID: 30272580
[TBL] [Abstract][Full Text] [Related]
6. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy.
Huang JL; Chang YT; Hong ZY; Lin CS
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328658
[TBL] [Abstract][Full Text] [Related]
7. When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity.
Pan D; Wang Q; Shen A; Qi Z; Zheng C; Hu B
Int J Cancer; 2024 Aug; 155(3):384-399. PubMed ID: 38655783
[TBL] [Abstract][Full Text] [Related]
8. Genomic instability drives tumorigenesis and metastasis and its implications for cancer therapy.
Guo S; Zhu X; Huang Z; Wei C; Yu J; Zhang L; Feng J; Li M; Li Z
Biomed Pharmacother; 2023 Jan; 157():114036. PubMed ID: 36436493
[TBL] [Abstract][Full Text] [Related]
9. Genomic instability and metabolism in cancer.
Li H; Zimmerman SE; Weyemi U
Int Rev Cell Mol Biol; 2021; 364():241-265. PubMed ID: 34507785
[TBL] [Abstract][Full Text] [Related]
10. Targeting DNA Repair.
Curigliano G
Handb Exp Pharmacol; 2018; 249():161-180. PubMed ID: 30341723
[TBL] [Abstract][Full Text] [Related]
11. Molecular chaperones in DNA repair mechanisms: Role in genomic instability and proteostasis in cancer.
Hasan A; Rizvi SF; Parveen S; Mir SS
Life Sci; 2022 Oct; 306():120852. PubMed ID: 35917940
[TBL] [Abstract][Full Text] [Related]
12. Noncoding RNAs in DNA Damage Response: Opportunities for Cancer Therapeutics.
Arjumand W; Asiaf A; Ahmad ST
Methods Mol Biol; 2018; 1699():3-21. PubMed ID: 29086365
[TBL] [Abstract][Full Text] [Related]
13. Endogenous DNA Damage as a Source of Genomic Instability in Cancer.
Tubbs A; Nussenzweig A
Cell; 2017 Feb; 168(4):644-656. PubMed ID: 28187286
[TBL] [Abstract][Full Text] [Related]
14. The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance.
Carloni V; Morganti E; Galli A; Mazzocca A
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613695
[TBL] [Abstract][Full Text] [Related]
15. Targeting the microRNA-regulating DNA damage/repair pathways in cancer.
Bottai G; Pasculli B; Calin GA; Santarpia L
Expert Opin Biol Ther; 2014 Nov; 14(11):1667-83. PubMed ID: 25190496
[TBL] [Abstract][Full Text] [Related]
16. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress.
Chroma K; Mistrik M; Moudry P; Gursky J; Liptay M; Strauss R; Skrott Z; Vrtel R; Bartkova J; Kramara J; Bartek J
Oncogene; 2017 Apr; 36(17):2405-2422. PubMed ID: 27841863
[TBL] [Abstract][Full Text] [Related]
17. Targeting the DNA damage response in immuno-oncology: developments and opportunities.
Chabanon RM; Rouanne M; Lord CJ; Soria JC; Pasero P; Postel-Vinay S
Nat Rev Cancer; 2021 Nov; 21(11):701-717. PubMed ID: 34376827
[TBL] [Abstract][Full Text] [Related]
18. A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer.
Ding K; He Y; Wei J; Fu S; Wang J; Chen Z; Zhang H; Qu Y; Liang K; Gong X; Qiu L; Chen D; Xiao B; Du H
Front Immunol; 2022; 13():943090. PubMed ID: 36081518
[TBL] [Abstract][Full Text] [Related]
19. Neoantigens and genome instability: impact on immunogenomic phenotypes and immunotherapy response.
Mardis ER
Genome Med; 2019 Nov; 11(1):71. PubMed ID: 31747945
[TBL] [Abstract][Full Text] [Related]
20. Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implication.
Lamberti G; Andrini E; Sisi M; Federico AD; Ricciuti B
Future Oncol; 2020 Aug; 16(23):1751-1766. PubMed ID: 32539551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
